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Abstract b-Catenin signaling, leading to the activation of
lymphoid enhancer-binding factor 1/T cell factor (LEF1/
TCF) transcription factors, plays a well-established role in
transcription regulation during development and tissue
homeostasis. In the adult organism, the activity of this
pathway has been found in stem cell niches and postmitotic
thalamic neurons. Recently, studies show that mutations in
components of b-catenin signaling networks have been
associated with several psychiatric disorders, indicating the
involvement of b-catenin and LEF1/TCF proteins in the
proper functioning of the brain. Here, we report a com-
prehensive analysis of LEF1/TCF protein localization and
the expression profile of their isoforms in cortical, thalamic,
and midbrain regions in mice. We detected LEF1 and
TCF7L2 proteins in neurons of the thalamus and dorsal
midbrain, i.e., subcortical regions specialized in the inte-
gration of diverse sources of sensory information. These
neurons also exhibited nuclear localization of b-catenin,
suggesting the involvement of b-catenin/LEF1/TCF7L2 in
the regulation of gene expression in these regions. Analysis
of alternative splicing and promoter usage identified brain-
specific TCF7L2 isoforms and revealed a developmentally
coordinated transition in the composition of LEF1 and
TCF7L2 isoforms. In the case of TCF7L2, the typical brain
isoforms lack the so-called C clamp; in addition, the dom-
inant-negative isoforms are predominant in the embryonic
thalamus but disappear postnatally. The present study pro-
vides a necessary framework to understand the role of
LEF1/TCF factors in thalamic and midbrain development
until adulthood and predicts that the regulatory role of these
proteins in the adult brain is significantly different from
their role in the embryonic brain or other non-neural tissues.
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Introduction
Lymphoid enhancer-binding factor 1/T cell factors (LEF1/
TCFs) are transcription factors activated by b-catenin in the
canonical Wnt signaling pathway. The induction of this
pathway, also called the Wnt/b-catenin pathway, leads to
the inhibition of b-catenin degradation and its subsequent
accumulation in the cytoplasm. b-Catenin can then be
translocated to the nucleus, bind to LEF1/TCF proteins, and
activate its target genes (Angers and Moon 2009; Mac-
Donald et al. 2009; Archbold et al. 2012). Canonical Wnt
signaling controls fundamental aspects of animal develop-
ment, such as the establishment of embryonic body plan, the
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expansion of progenitor cells, and lineage decisions in
every major organ, including the central nervous system
(McMahon et al. 1992; Galceran et al. 2000; Mukhopad-
hyay et al. 2001; Maretto et al. 2003; Logan and Nusse
2004; Zhou et al. 2004; Ciani and Salinas 2005; Grigoryan
et al. 2008; Petersen and Reddien 2009; Freese et al. 2010;
Niehrs 2010). In the adult, Wnt signaling activity is largely
restricted to stem cell reservoirs (Maretto et al. 2003;
Haegebarth and Clevers 2009; Wend et al. 2010). For
example, Wnt signaling has been reported in neural pro-
genitor cells in the subgranular zone of the hippocampus
(Lie et al. 2005; Kuwabara et al. 2009). b-Catenin also
accumulates in the cell bodies of postmitotic thalamic
neurons on a constant basis and independently of signal
transduction through Wnt receptors (Lucas et al. 1999;
Wisniewska et al. 2010; Misztal et al. 2011; Pratt et al.
2012).
The LEF1/TCF family has four members in mammals:
TCF7, TCF7L1, TCF7L2 (also known as TCF1, TCF3, and
TCF4, respectively), and LEF1 (Arce et al. 2006; Archbold
et al. 2012). They contain a b-catenin-binding domain at
the N-terminus and a high-mobility group domain at the
central part that recognizes the WWCAAAG DNA
sequence, known as Wnt responsive element (WRE) (van
de Wetering et al. 1997; van Beest et al. 2000; Barolo
2006; Hallikas et al. 2006; Chang et al. 2008). Despite the
high sequence similarity among LEF1/TCF family mem-
bers in these two domains, they display different promoter
specificities within a particular cellular context. Moreover,
the diversity of LEF1/TCF proteins is further increased by
alternative promoter usage and extensive alternative
splicing (Arce et al. 2006; Archbold et al. 2012). These
isoforms can be categorized into several classes. One set of
isoforms lacks the b-catenin-binding domain and acts as
dominant-negative forms (Roose et al. 1999; Hovanes et al.
2000). Another group results from the alternative splicing
of C-terminal exons, which encode an additional DNA-
binding domain, the C clamp, found in some LEF1/TCFs
(Van de Wetering et al. 1996; Duval et al. 2000; Hovanes
et al. 2000; Nazwar et al. 2009; Weise et al. 2010; Vacik
et al. 2011). This domain has been shown to make a contact
with a type of GC-rich element, the so-called TCF-Helper
sequence, located on either side of WRE. The C clamp
dramatically increases the DNA-binding affinity and
enables transcriptional regulation of a distinct set of the
target genes (Hovanes et al. 2001; Hecht and Stemmler
2003; Atcha et al. 2007; Chang et al. 2008; Hoverter et al.
2012). Finally, the alternative splicing of other domains
may modify the properties of LEF1/TCFs, e.g. affect their
ability to act as either repressors or activators (Gradl et al.
2002; Liu et al. 2005; Ghogomu et al. 2006).
In contrast to the well-established roles of LEF1/TCF
and b-catenin during development (Yamaguchi 2001;
Logan and Nusse 2004; Ciani and Salinas 2005; Petersen
and Reddien 2009; Freese et al. 2010; Niehrs 2010;
Archbold et al. 2012), the potential functions of these
proteins in the adult brain remain obscure. Several recent
observations point to an important role of these factors in
proper brain function and its pathologies. For example,
variants of the TCF7L2 gene have been associated with
schizophrenia (Hansen et al. 2011; Alkelai et al. 2012), and
anxiety-like phenotypes were observed in Tcf7l2 haplo-
insufficient mice (Savic et al. 2011), suggesting the
involvement of TCF7L2 in some psychiatric disorders. In
addition, several other Wnt pathway components, such as
FZD3, GSK-3b, DKK4, and APC, have been shown to be
associated with susceptibility to schizophrenia (Cui et al.
2005; Kishimoto et al. 2008; Proitsi et al. 2008; Li et al.
2011), and many proteins mutated in sporadic autism are
part of the b-catenin signaling network (O’Roak et al.
2012). A neural role of this pathway is further supported by
the finding that LEF1/TCF can regulate genes that encode
proteins implicated in neuronal excitability in the thalamus
(Wisniewska et al. 2010), one of the regions that often
exhibits abnormalities in schizophrenia (Byne et al. 2009;
Cronenwett and Csernansky 2010; Pinault 2011; Guller
et al. 2012). During embryonic development, Tcf7l2 is
primarily expressed in the thalamic and pretectal neuro-
epithelial domains at early stages of vertebrate develop-
ment. This expression is subsequently extended to the
midbrain and other forebrain regions during early steps of
the specification of postmitotic neuroepithelial cells in all
studied vertebrates (Cho and Dressler 1998; Ferran et al.
2007; Bluske et al. 2009; Quinlan et al. 2009; Mercha´n
et al. 2011; Morona et al. 2011). However, expression data
are much scarcer for postnatal stages. In the adult mouse
brain, the Tcf7l2 transcript has been described in the thal-
amus, pretectum, and some midbrain derivatives (Lee et al.
2009). During embryogenesis Lef1 is detected in the thal-
amus pretectum and midbrain in mouse, chick and zebra-
fish (Bluske et al. 2009; Quinlan et al. 2009; Peukert et al.
2011), and is observed in the adult mouse and monkey
thalamus (Jones and Rubenstein 2004; Shimogori et al.
2004). LEF1 protein was detected in postmitotic thalamic
neurons in the zebrafish and adult rat (in the latter co-
localizing with nuclear b-catenin) (Wisniewska et al. 2010;
Misztal et al. 2011; Peukert et al. 2011). Therefore, as a
first step to understand the physiological role of the LEF1/
TCF transcriptional regulators in adult brain function,
comprehensively examining their expression levels and
alternative splicing variants and describing b-catenin and
LEF1/TCF protein localization in detail are necessary.
Here, we used quantitative polymerase chain reaction
(qPCR) to measure the absolute expression levels of all
LEF1/TCF genes in the cortex, thalamus, and midbrain
from the late gestational stage to adulthood, distinguishing
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between full-length and dominant-negative isoforms. This
was followed by an analysis of alternatively spliced forms
of Lef1 and Tcf7l2 and their protein products in the
embryonic and adult thalamus. Finally, we performed
immunohistochemical staining to provide a detailed map of
LEF1 and TCF7L2 protein distribution in cortical, tha-
lamic, and mesencephalic regions in adult mice. We also
established their co-localization with b-catenin and the
neuronal marker NeuN. This study provided the first
in-depth map of LEF1/TCF expression at postnatal stages.
Materials and methods
Animals
C57BL/6 mice were housed under standard conditions on a
12 h/12 h light/dark cycle (lights on at 7:00 a.m.) with food
and water available ad libitum. All of the experimental
procedures were approved by the Polish local Ethical
Committee No. 1 in Warsaw.
Antibody characterization
Anti-TCF4 (6H5-3) mouse monoclonal antibody was
raised against amino acids 31-331 of human TCF7L2
(Millipore). Brain staining patterns of this antibody repli-
cate the published Tcf7l2 mRNA pattern determined by
in situ hybridization (Lee et al. 2009). This antibody was
previously shown to recognize different C-terminal mouse
isoforms on immunoblots (bands 50–70 kDa) and by
immunofluorescence (Weise et al. 2010).
Anti-TCF4 (N-20) goat polyclonal affinity-purified
antibody was raised against a peptide that maps amino
acids 1-50 in the N-terminus of TCF7L2 of human origin
(Santa Cruz Biotechnology). The staining pattern is iden-
tical to mouse anti-TCF4 6H5-3 antibody. This goat anti-
body was previously shown to recognize different
C-terminal mouse isoforms on immunoblots (bands
50–70 kDa) (Weise et al. 2010).
Anti-TCF4 (C48H11) rabbit monoclonal antibody was
raised against a synthetic peptide that corresponds to resi-
dues that surround Leu330 of human TCF7L2 (Cell Sig-
naling Technology). This antibody shows bands that
correspond to known TCF7L2 isoforms on Western blots
of mouse brain structures and colon nuclear fractions and
HeLa cells that express recombinant TCF7L2 isoforms
(Fig. 3e). This is consistent with a previous report (Vacik
et al. 2011).
Anti-LEF1 (N-17) goat polyclonal antibody was raised
against amino acids 1–50 mapped to the N-terminus of
human LEF-1 (Santa Cruz Biotechnology). The antibody
recognizes endogenous LEF1 protein on Western blots of
whole-cell lysates from lymphoblastic lymphoma cell lines
and immortalized T lymphocytes (manufacturer’s technical
information). This antibody was previously shown to stain
lung mesenchyme (Yin et al. 2008) and rat brain (Wis-
niewska et al. 2010). The observed staining pattern was
consistent with previously reported in situ hybridization
experiments in mouse brains (Jones and Rubenstein 2004;
Shimogori et al. 2004).
Anti-LEF1 (C18A7) rabbit monoclonal antibody was
produced by immunizing animals with a synthetic peptide
that corresponds to residues that surround Pro82 of human
LEF1 (Cell Signaling Technology). The antibody recog-
nizes endogenous LEF1 protein, including isoforms that
lack the N-terminus, on Western blots of total cell lysates
from mouse thymocytes, DLD1 cells, and HCT15 cells
(manufacturer’s technical information). This antibody was
also used to detect endogenous and recombinant protein on
Western blots (Hoeppner et al. 2011). In our Western blot
analysis of nuclear fractions of mouse brain structures and
the thymus and extracts of HeLa cells that express
recombinant LEF-HA protein, we observed bands that
were consistent with known isoforms (Fig. 2d).
Anti-b-catenin (H-102) rabbit polyclonal antibody was
raised against amino acids 680–781 that mapped to the
C terminus of b-catenin of human origin (Santa Cruz
Biotechnology). This antibody recognizes the expected
band around 92 kDa on Western blots from different brain
structure homogenates and shows both membrane and
nuclear staining of b-catenin on rat immunohistochemical
brain sections (Wisniewska et al. 2010).
Anti-NeuN mouse monoclonal antibody was raised
against purified cell nuclei from mouse brain. It reacts with
most neuronal cell types and is frequently used as a pan-
neuronal marker (Millipore). Immunohistochemical stain-
ing is primarily in the nuclei of the neurons. On Western
blots, it recognizes two to three bands in the 46–48 kDa
range.
DNA constructs
The expression plasmids used for heterologous expression
have been published previously. Mouse Lef1 was a kind
gift from Prof. Rudolf Grosschedl (Max Planck Institute of
Immunobiology, Freiburg, Germany). Tcf7l2-E2, Tcf7l2-
S2, Tcf7-B, and Tcf7l1 were obtained from Prof. Andreas
Hecht (Institute of Molecular Medicine and Cell Research,
Freiburg, Germany). The Tcf7l2-S3 splice variant sequence
(described in Weise et al. 2010) was amplified from the
Tcf7l2-S2 plasmid by PCR using the 50-ATTCTAGA
ATGCCGCAGCTGAACGG-30 primer that incorporates
the XbaI site and 50-GCGGCCCCTGCAGTTTGTAGGTA
Brain Struct Funct (2013) 218:1531–1549 1533
123
CCAA-30 primer that incorporates the KpnI site. The PCR
product was cloned into a pCG vector.
HeLa cell transfection
HeLa cells (ATCC) were cultured according to the manu-
facturer’s instructions. A total of 1 9 106 cells were seeded
on a six-well plate 1 day before transfection, which was
performed with 0.25 lg of expression plasmids together
with 0.5 lg empty plasmid. Twenty microliters of OPTI-
MEM medium (Invitrogen) and 2 ll of 1 mg/ml poly-
ethylenimine (PEI) were added to the DNA, vortexed, and
incubated for 15 min at room temperature. The mixture was
then diluted with 120 ll of complete medium and added to
the cells. The cells were further processed after 48 h.
Protein extraction and immunoblotting
HeLa cells that overexpressed LEF1-HA and TCF7L2-E2
and TCF7L2-S3 isoforms were lysed in radioimmunopre-
cipitation assay buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, 1 mM ethylenediaminetetraacetic acid [EDTA], 1 %
NP40, 0.5 % Na-deoxycholate, 0.1 % sodium dodecyl
sulfate [SDS], and Complete protease inhibitor cocktail
[Roche]), homogenized, briefly sonicated, and cleared by
centrifugation at 12,0009g at 4 C for 10 min.
For the preparation of nuclear extracts, the cortex, thala-
mus, and midbrain from embryonic (embryonic day 18.5
[E18.5]) and adult mice, adult gut, and adult thymus were
dissected. The tissues were homogenized in ice-cold lysis
buffer (50 mM Tris–HCl, pH 7.4, 5 mM MgCl2, 1 mM DTT,
and Complete protease inhibitor cocktail [Roche]), followed
by centrifugation at 8009g for 10 min. The supernatants were
removed, and the pellets (i.e., nuclear fractions) were washed
in lysis buffer and again centrifuged. The nuclear pellets were
resuspended in hypotonic swelling buffer (20 mM HEPES,
pH 7.9, 50 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM
DTT, and Complete protease inhibitor cocktail [Roche]) and
incubated for 30 min with gentle rocking at 4 C. The nuclear
extracts were briefly sonicated, cleared by centrifugation at
9,0009g at 4 C for 30 min, and stored at -80 C until use.
The protein concentrations in cell lysates and nuclear
extracts were determined using the Bradford Protein Assay kit
(BioRad). For Western blotting, 20 lg of nuclear extracts and
1 lg of HeLa lysates were separated by electrophoresis on a
10 % SDS–polyacrylamide gel and transferred to a nitrocel-
lulose membrane (Whatmann). The blots were blocked with
5 % dry non-fat milk powder in Tris-buffered saline with
0.5 % Tween 20 (TBST), washed 3 9 5 min with TBST, and
incubated overnight at 4 C with rabbit anti-LEF1 (1:1,000;
C18A7, Cell Signaling Technology) and rabbit anti-TCF4
(1:1,000; C48H11, Cell Signaling Technology) antibodies
diluted in 0.5 % milk in TBST. After three washes in TBST,
membranes were probed with anti-rabbit secondary horse-
radish peroxidase (HRP)-conjugated antibody. Immunoreac-
tivity was visualized with a chemiluminescent substrate
solution that consisted of 0.1 M Tris–HCl, pH 8.6, 1.25 mM
luminol, 0.23 mM p-Coumaric acid, and 0.0003 % H2O2.
RNA isolation and cDNA preparation
Embryonic E16.5 to adult mouse brains were removed and
placed on ice for the isolation of the cortex, thalamus and
midbrain. The thalamus was dissected rostral to the supe-
rior colliculus in a line that pass approximately in the
habenulo-interpeduncular tract, that is the caudal landmark
of the thalamic region. Sectioned brain structures were
immediately snap-frozen in liquid nitrogen and kept at
-80 C until RNA isolation. The RNA was isolated using
a lipid-tissue designed kit (RNeasy for Lipid Tissue, Qia-
gen) and additionally treated with DNase (Qiagen). The
RNA (2 lg) was transcribed to cDNA using the Super-
Script III RNase H-Reverse Transcriptase kit (Invitrogen)
according to the manufacturer’s instructions.
Reverse-transcription quantitative polymerase chain
reaction
The level of mRNA was examined using SYBR Green
chemistry (Applied Biosystems) and probes designed using
PrimerQuestSM on a 7900HT Fast Real-Time PCR System
(Life Technologies). Reverse-transcription qPCR (RT-qPCR)
was performed on cDNA synthesized from 20 ng of total
RNA per point. The primers were designed to cover all known
isoforms. The sequences of the used primers are listed in
Table 1. Copy numbers were calculated using standard curves
(102–107 copies) generated with serial dilutions of linearized
plasmids that carry Lef1, Tcf7, Tcf7l1, and Tcf7l2 cDNAs.
Splicing analysis and reverse-transcription polymerase
chain reaction
To investigate all possible isoforms generated from mouse
Lef1 and Tcf7l2, we combined information from previous
publications (Carlsson et al. 1993; Roose et al. 1999; Duval
et al. 2000; Hovanes et al. 2000; Pukrop et al. 2001;
Young et al. 2002; Nazwar et al. 2009; Weise et al. 2010;
Vacik et al. 2011), available estimated sequence tags and
mRNAs from National Center for Biotechnology databases,
and Ensembl genome annotations for mouse, human, and
zebrafish. Each potential alternative splicing event was
manually annotated in the mouse genomic sequence
(Figs. 2a, 3a), and different sets of primers were designed to
cover all possible alternative splicing events. In general,
primers were designed on adjacent constitutive exons that
spanned the entire alternative region, with the exception of
1534 Brain Struct Funct (2013) 218:1531–1549
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investigating the possible inclusion/exclusion of exons 5b
and 12 in Tcf7l2. For primer design, we used Primer3
software, requiring that the ratio between short and long
isoforms did not exceed 1:2, when possible, to minimize
biased PCR amplification of short amplicons (Rukov et al.
2007). For RT-PCR, cDNA according to 50 ng RNA was
amplified using the primers listed in Table 1 and Taq DNA
polymerase (EURx Ltd). PCR products were separated by
electrophoresis on 2.5 % agarose gels.
RNA-seq analysis
For RNA-seq analysis, we prepared Bowtie sequence
libraries with all possible exon–exon junctions for both
genes and mapped RNA-seq from mouse brain, liver,
kidney, and heart (Brawand et al. 2011) using bowtie with
–m 1 –v 2 parameters. The inclusion level for each alter-
native sequence and sample was determined as previously
described (Ellis et al. 2012).
Perfusion of mice and brain sectioning
Male mice (P60) were deeply anesthetized with an intra-
peritoneal injection of Morbital and transcardially perfused
with a 0.1 M phosphate-buffered saline (PBS) solution, pH
7.4, followed by 4 % paraformaldehyde in 0.1 M PBS, pH
7.4. Dissected brains were postfixed overnight and further
cryoprotected overnight with 30 % sucrose. The brains
were coronally sectioned at 40 lm with a cryostat.
Immunocytochemistry
Free-floating sections were first quenched with 0.3 % H2O2
for 10 min and rinsed in PBS that contained 0.2 % Triton
X-100 (PBST; 3 9 10 min), blocked for 30 min with 3 %
serum of the appropriate species in PBST, and incubated
with primary antibodies (mouse anti-TCF4, 1:1,000, Milli-
pore; goat anti-LEF-1, 1:200, Santa Cruz Biotechnology;
rabbit anti-b-catenin, 1:1,000, Santa Cruz Biotechnology)
diluted in 1 % serum in PBST. After washing, the sections
were incubated with biotinylated secondary anti-rabbit, anti-
goat, or anti-mouse antibodies (1:500; Vector Labs). Stain-
ing was visualized by a reaction with 3,30-diaminobenzidine
substrate using an ABC kit (Vector Labs). When using anti-
mouse primary antibody, the Vector M.O.M. Immunode-
tection Kit (Vector Labs) was used. Photographs were taken
with a Nikon Eclipse 80i microscope.
Immunofluorescence
Free-floating sections were blocked for 30 min with 3 %
serum of the appropriate species in PBST and incubated with
primary antibodies (goat anti-TCF4, 1:500, Santa Cruz Bio-
technology; goat anti-LEF-1, 1:100, Santa Cruz Biotechnol-
ogy; rabbit anti-b-catenin, 1:500, Santa Cruz Biotechnology;
mouse anti-NeuN, 1:500, Millipore) diluted in 1 % serum in
PBST. For multiple fluorescent immunostainings, sections
were incubated with combinations of appropriate secondary
antibodies conjugated with Alexa Fluor 488 and 568 dyes
(1:500; Molecular Probes) for 1 h before they were mounted
onto slides with Vectashield medium (Vector Labs). Photo-
graphs were taken with a Nikon Eclipse 80i microscope.
Image processing
Digital microscopic images were slightly modified to
optimize image resolution, brightness, and contrast using
Adobe Photoshop CS4 software to best represent the
immunohistochemistry and immunofluorescence observed
with the microscope.
Results
Expression levels of Lef1, Tcf7, Tcf7l1, and Tcf7l2
mRNA in the developing and adult cortex, thalamus,
and midbrain
We analyzed the expression of LEF1/TCF transcription
factors in the regions where their expression has been
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previously reported during late development, i.e., in the
thalamus and midbrain. In addition, we included the cortex
because of the thalamocortical and corticothalamic rela-
tionships described in the developing (Pratt et al. 2012) and
adult (Steriade 1997) brain.
To provide accurate measurements of mRNA levels, we
first performed RT-qPCR and used standard curves to cal-
culate mRNA copy numbers. The level of mRNA of every
LEF1/TCF gene (Lef1, Tcf7, Tcf7l1, and Tcf7l2) was quan-
tified in the embryonic (E16.5 and E18.5), postnatal (post-
natal day 0 [P0], P10, and P30), and young adult (P60)
thalamus and cortex, as well as in the E16.5 and P60
midbrain (Fig. 1a–d). For comparison, we isolated RNA
from the thymus, where high levels of Lef1 and Tcf7 are
present in T lineage lymphocytes (Waterman et al. 1991; Van
de Wetering et al. 1996), and colon, where Tcf7 and Tcf7l2
are expressed in epithelial stem cells throughout life
(Korinek et al. 1998a; Roose et al. 1999). As a reference
frame, we considered less than 1,000 mRNA molecules per
1 ng of total RNA as a low expression level, between 1,000
and 10,000 as a moderate expression level, and[10,000 as a
high expression level. For further estimations, we assumed
that 1 ng of total RNA comes from*40 brain cells, including
both neurons and astrocytes (Norton and Poduslo 1971).
Fig. 1 Expression analysis of the Lef1, Tcf7, Tcf7l1, and Tcf7l2
genes. mRNA copy numbers of a Lef1, b Tcf7, c Tcf7l1, and d Tcf7l2
were measured in the developing and adult cortex, thalamus, and
midbrain and adult thymus and colon. The results are shown as
mRNA copy number per 1 ng of total RNA (estimated to correspond
to *40 brain cells). Copy numbers were calculated using standard
curves generated with serial dilutions of linearized plasmids that carry
Lef1, Tcf7, Tcf7l1, and Tcf7l2 cDNAs. The data are expressed as
mean ± SD (n = 3), except for the thymus and colon. Comparisons
between copy numbers of full-length (FL) and truncated isoforms of
e Lef1 and f Tcf7l2 in the developing thalamus were made using
different primer pairs, the positions of which are marked in Figs. 2a
and 3a, respectively. The data are expressed as mean ± SD (n = 3).
g The pie chart indicates the percentage contribution of full-length
(FL) and dominant-negative (dn) Tcf7l2 isoforms in the embryonic
and adult thalamus
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The mRNA level of Lef1 was moderate in the devel-
oping and adult thalamus (estimated to be *50 copies/
cell) and developing midbrain and low in the adult mid-
brain and developing and adult cortex (Fig. 1a). Interest-
ingly, whereas Lef1 mRNA levels appeared to significantly
decrease in the midbrain during development, they
remained constant in the thalamus throughout all of the
studied stages (Fig. 1a). In the case of Tcf7, mRNA
expression was low in all of the samples (5–10 copies/cell),
with the exception of the thymus, where it was extremely
high (Fig. 1b). Virtually no expression of Tcf7l1 (\1 copy/
cell) was found in any of the analyzed tissue (Fig. 1c). In
contrast, Tcf7l2 mRNA level was high in the embryonic
and perinatal thalamus (*2,000 copies/cell). Although it
gradually decreased approximately fourfold during devel-
opment, it still remained high (*400 copies/cell) in the
adult (Fig. 1d). In the midbrain and E16.5 cortex, Tcf7l2
mRNA levels were moderate and then gradually decreased
to a low level in the latter.
Lef1 and Tcf7l2 genes have been previously shown to
contain alternative promoters located in introns 2 and 5,
respectively, which generate truncated mRNA isoforms that
encode dominant-negative proteins (Hovanes et al. 2000;
Vacik et al. 2011). We estimated the specific contribution of
these truncated forms to the total pool of mRNAs from each
gene during thalamus development. For each gene, a pair of
primers that specifically target the most-upstream canonical
first exons was designed (Figs. 2a, 3a). In the case of Lef1,
all of the transcripts in the thalamus corresponded to full-
length isoforms because the estimated levels were similar to
the full-length-specific primers and primers common to all
isoforms (Fig. 1e). Accordingly, RNA-seq data from the
adult mouse brain supported the use of only the upstream
promoter in this tissue. The truncated Tcf7l2 mRNA was the
predominant isoform in the embryonic thalamus (Fig. 1f)
and constituted almost 70 % of all of the estimated mRNA
molecules for this gene (Fig. 1g; this estimation was made
by subtracting the short form-specific RT-qPCR measure-
ment from the value obtained with a pair of primers com-
mon to all isoforms). The contribution of this dominant-
negative isoform decreased by approximately 25 % during
postnatal development but was still significantly high
(Fig. 1g). The RNA-seq analysis of the whole adult brain
supported the expression of the truncated Tcf7l2 isoform
from the alternative promoter located in intron 5.
In summary, Lef1 and Tcf7l2 mRNAs were the pre-
dominant members of the LEF1/TCF family in the thala-
mus and midbrain, whereas all of the members exhibited
low expression in the cortex. Moreover, the truncated,
dominant-negative Tcf7l2 isoforms were the most abundant
isoforms in the embryonic thalamus but not in the adult
thalamus, while Lef1 was expressed only as full-length
isoforms at all of the studied stages.
Fig. 2 Analysis of alternative splicing of Lef1 in the mouse thalamus.
a Representative intron–exon structure of the Lef1 gene. Long introns
are represented by a double slash. Blue boxes indicate the alterna-
tively spliced exons. Important protein domains are marked by red
and green lines under the exons by which there are encoded. The
position and orientation of the primers used for RT-PCR are indicated
by horizontal arrows. The horizontal lines with ‘‘Lef1 FL’’ and
‘‘Lef1’’ indicate the regions of the gene that were tested in the RT-
qPCR analysis in Fig. 1. b RT-PCR expression analysis of alternative
splicing of exon 6. c RT-PCR expression analysis of alternative
splicing of exon 11. d Western blot analysis of the endogenous LEF1
protein in the E18.5 and adult cortex (Cx), thalamus (Th), and
midbrain (Mb) and adult thymus. Fast-migrating polypeptides in the
thymus may represent alternative forms of LEF1, degradation
products, or other nonspecific proteins. As a control, HeLa cells
transfected with LEF1-HA expression plasmids were used
Brain Struct Funct (2013) 218:1531–1549 1537
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Identification of Lef1 splice variants in the embryonic
and adult mouse thalamus
The LEF/TCF family exhibits not only alternative pro-
moter usage but also extensive alternative splicing, giving
rise to isoforms with unique specificities for promoter
recognition and activation (see ‘‘Introduction’’). Therefore,
we also analyzed the splicing patterns of Lef1 and Tcf7l2 in
the developing and adult brain. Given that the expression
of these genes was the highest in the thalamus, we chose
this region for analysis and compared it with the adult
thymus and colon where Lef1 and Tcf7l2 are highly
expressed, respectively. For this purpose, we reverse tran-
scribed RNA isolated from the above tissues and PCR-
amplified specific sequences of the Lef1 and Tcf7l2 cDNA
with primers designed to span specifically the alternative
splicing regions. We also analyzed RNA-seq data from
different adult tissues, including whole brain, by measuring
reads that span alternative exon–exon junctions and 30 and
50 alternative splice sites.
An in-depth analysis of the mouse Lef1 intron–exon
structure revealed two alternative first exons and two
alternative splicing events (Fig. 2a) conserved to the
human gene (Hovanes et al. 2000). The first alternative
splicing event resulted in the skipping of exon 6 (Fig. 2b),
which overlaps with an important regulatory domain
(Carlsson et al. 1993; Mallory et al. 2011). This alternative
splicing event showed a dramatic regulatory switch during
development. Exon 6 was mostly skipped in the E18.5
thalamus, and nearly all of the transcripts include the exon
by P60. Similarly, the adult thymus exhibited nearly no
skipping of exon 6. We then investigated the second
alternative exon (exon 11) located at the 30 region of the
Lef1 gene (Fig. 2c). The inclusion of exon 11 causes a
Fig. 3 Analysis of alternative splicing of Tcf7l2 genes in the mouse
thalamus. a Representative intron–exon structure of the Tcf7l2 gene.
Long introns are represented by a double slash. Blue boxes indicate the
alternatively spliced exons. Important protein domains are marked by
red, green and blue lines under the exons by which there are encoded.
The position and orientation of the primers used for RT-PCR are
indicated by horizontal arrows. The horizontal lines with ‘‘Tcf7l2 FL’’
and ‘‘Tcf7l2’’ indicate the regions of the gene that were tested in the
RT-qPCR analysis in Fig. 1. b RT-PCR expression analysis of
alternative splicing of exon 4. c RT-PCR expression analysis of
alternative splicing of exon 5. d RT-PCR expression analysis
of alternative splicing of exons 13–16. Colon transcript resulted from
inclusion of exon 14 or 15 translated from different alternative reading
frame (ARF). e Western blot analysis of the endogenous TCF7L2
protein in the E18.5 and adult cortex (Cx), thalamus (Th), and midbrain
(Mb) and adult colon. As a control, HeLa cells transfected with
TCF7L2-E2 and TCF7L2-S3 expression plasmids were used
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frame shift in the transcript, generating a slightly shorter
isoform because of the introduction of a premature stop
codon [short and long forms correspond to N and B iso-
forms in humans, respectively (Hovanes et al. 2000)].
Although less pronounced than for exon 6, exon 11 also
exhibited strong developmental regulation, with increasing
inclusion of this exon from P18.5 to P60 in the thalamus.
The adult thymus exhibited no exon skipping. Consistent
with the RT-PCR results, RNA-seq data from the adult
brain showed high inclusion levels for both exons 6 and 11
(96 and 69 %, respectively).
To determine whether these alternative splicing events
have an impact at the protein level, we performed a Wes-
tern blot analysis with nuclear extracts from the embryonic
and adult cortex, thalamus, and midbrain and adult thymus
(Fig. 2d). In the embryonic tissues, we observed two *53
to 54 kDa protein bands that corresponded to isoforms
generated by the alternative splicing of exon 11. The more
slowly migrating band, which was more prominent in the
thalamus and midbrain than in the cortex, represented the
long protein isoform that resulted from exon 11 exclusion.
The band with higher electrophoretic mobility corre-
sponded to the short protein isoform that included exon 11.
Consistent with the RT-PCR analysis, the inclusion of exon
6 was widespread in the adult thalamus and midbrain,
resulting in an increase in the molecular weight of the
LEF1 protein. In addition, we observed a downregulation
of LEF1 protein levels in the P60 thalamus compared with
the E18.5 thalamus, in contrast to generally constant
mRNA levels. Finally, we did not detect dominant-nega-
tive LEF1 isoforms (*37 kDa) in any of the analyzed
brain regions, in contrast to the adult thymus. In summary,
Table 2 Relative regional expression of LEF1, TCF7L2, and nuclear b-catenin in the mouse forebrain and midbrain
Region LEF1 TCF7L2 Nuclear
b-catenin
Region LEF1 TCF7L2 Nuclear
b-catenin
Cerebral cortex - -* - Thalamus (continued)
Corpus callosum - -* - Reuniens ?? ??? ???
Hippocampal formation - -* - Mediodorsal ??? ?? ???
Entorhinal cortex, lateral ??/??? - - Ventral anterolateral ??? ???? ???
Striatum - -* - Ventral Medial ???? ??? ???
Pallidum Ventral posterolateral ??? ?? ???
Ventral pallidum - ? ? Ventral posteromedial ??? ??? ???
Substantia innominata - ? ? Laterodorsal ??? ??? ???
Magnocellular preoptic nucleus - ? ? Posterior ??? ???? ???
Nucleus of the horizontal limb
of the diagonal band
- ? ? Lateral posterior ??? ???? ???
Preoptic area - ? ? Parafascicular ± ??? ???
Prethalamus Submedius ??? ??? ???
Reticular - - - Dorsal lateral geniculate ??? ??? ???
Pregeniculate - ? ? Medial geniculate ??? ??? ???
Zona incerta - - - Pretectal region - ?? ??
Epithalamus Periaqueductal gray
Medial habenula ; ?? ???? Dorsomedial ? ? ??
Lateral habenula - - - Dorsolateral ? ?? ??
Thalamus Lateral - ?? ?
Paraventricular - ??? ???/???? Ventrolateral - - -
Parataenial ? ??? ??? Superior colliculus
Anteroventral ?? ??? ??? Zona layer ?? - ??
Anteromedial ?? ??? ?? Superficial gray layer ?? - ??
Anterodorsal ? ??? ??/??? Optic nerve layer ?? ? ??
Central medial ? ??? ?? Intermediate layers ?? ? ??
Rhomboid ?? ??? ??? Deep layers ?? ? ??
Paracentral ? ??? ??? Interpeduncular medial nucleus - ? ?
Intermediodorsal ? ??? ??? Inferior colliculus - ??/??? -
The relative intensity of nuclear immunostaining or number of cells that express LEF1, TCF7L2, and b-catenin in the specified brain regions is
summarized. The intensity of nuclear labeling was estimated as highest (????), high (???), moderate (??), low (?), background/no
labeling (-), or small number of none-neuronal cells stained (-*)
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we observed a developmentally coordinated switch in the
regulation of Lef1 isoform composition, with increased
inclusion of both exons 6 and 11, and also downregulation
at the protein level.
Identification of Tcf7l2 splice variants in the embryonic
and adult mouse thalamus
Tcf7l2 can give rise to diverse proteins by combining
several alternatively spliced exons that are scattered
throughout the entire length of the gene (Fig. 3a). We first
determined the inclusion of exon 4, which encodes part of a
domain involved in protein–protein interactions with
repressors and activators (Arce et al. 2006; Archbold et al.
2012) and whose exclusion was shown to have dampening
effects on Tcf7l2 transactivation capacity (Weise et al.
2010). This exon had clear tissue-specific regulation, with
both E18.5 and adult thalamus samples showing only
*25 % inclusion, whereas nearly all transcripts expressed
in the colon included exon 4 (Fig. 3a). This difference is
consistent with the RNA-seq data, in which inclusion in the
liver and kidney was 40 and 20 % higher, respectively,
than in the whole brain. We next investigated the alterna-
tive splicing of exon 5, which has been reported to be
alternatively spliced in zebrafish (Young et al. 2002), and a
previously uncharacterized exon between exons 5 and 6
(exon 5b in Fig. 3a). We used primers that spanned the
constitutive exons 3 and 6, yielding several RT-PCR
products (Fig. 3c). We observed the inclusion of exon 5 in
both examined tissues but found no support for the inclu-
sion of exon 5b. We then used RNA-seq to analyze the use
of two alternative splice site choices at exon 7 (alternative
50 splice site) and exon 9 (alternative 30 splice site), whose
alternative products were too short to be distinguished by
RT-PCR. In the case of exon 7, the 12-nucleotide alter-
native sequence was included in 80 % of the transcripts in
whole adult brain and nearly all of the transcripts in the
liver and kidney (*95 %). The 15-nucleotide sequence of
exon 9 was excluded in 98 % of the transcripts in the brain,
with slightly higher inclusion levels in the other tissues
(25–27 %). Finally, we investigated transcripts generated
at the 30 site of Tcf7l2. We first tested whether exon 12 was
alternatively spliced, as predicted in the Ensembl annota-
tions. Primer pairs that spanned exons 11 and 17 showed no
evidence of the exclusion of exon 12 in the studied tissues
and developmental stages (data not shown). We then
focused on the combinatorial diversity generated by alter-
native splicing of exons 13-16, which generates isoforms
with different C termini, namely TCF7L2-E harboring
complete C clamp, TCF7L2-S with incomplete version of it
and TCF7L2-M without C clamp (Weise et al. 2010). We
examined the RT-PCR products obtained from primers
that target exons 12 and 17 (Fig. 3d). The pattern of the
RT-PCR products from the thalamus showed that the
transcript that included exons 13, 14, and 16 was the most
prevalent isoform in the thalamus. This observation was
confirmed by sequencing the RT-PCR products. This
combination of exons, when translated, gives rise to a
TCF7L2-S isoform, i.e. with a truncated C clamp. In
contrast, the most abundant transcripts in the colon resulted
from the exclusion of exons 13 and 16 and inclusion of
either exon 14 or 15, which give rise to TCF7L2-E iso-
forms that have a complete C clamp. These results are
consistent with the RNA-seq data, which showed no
inclusion of exons 13 and 16 for the liver or kidney and
*40 % inclusion of exon 13 in the brain. Therefore, the
inclusion of exons 13 and 16 appeared to be highly tissue
specific. To detect the endogenous proteins in the brain
tissues, we performed a Western blot analysis using an
antibody that recognizes all of the isoforms of TCF7L2
(Fig. 3e). In the embryonic thalamus and midbrain, we
observed two predominant bands. The more slowly
migrating 58 kDa corresponded to the TCF7L2-S isoforms,
whereas the more rapidly migrating 35 kDa band matched
the molecular weight of the dominant-negative TCF7L2-S
isoform. Consistent with the RT-PCR data, we did not find
any developmental change in splicing composition. How-
ever, in the adult thalamus and midbrain, the level of the full-
length TCF7L2-S isoform proteins was reduced but still easy
to detect, while the dominant-negative TCF7L2-S isoform
was barely detected. In the cortex, we did not observe any of
the TCF7L2 isoforms at any of the analyzed stages.
In summary, in contrast to the coordinated temporal
regulation of Lef1 alternative splicing, Tcf7l2 events
showed remarkable tissue-specific coordinated regulation,
with the predominant isoforms in the thalamus lacking
exon 4 and including exons 13, 14, and 16 translated to
TCF7L2 with a truncated C clamp. Despite the lack of
temporal regulation of Tcf7l2 alternative splicing, we
observed a change in alternative promoter usage, with full-
length isoforms, i.e., the isoforms that contain a sequence
for the b-catenin-binding domain, predominating in the
adult thalamus.
Distribution of LEF1, TCF7L2, and nuclear b-catenin
in the adult mouse brain
The final aim of our study was to investigate the fine-scale
spatial protein distribution of LEF1/TCF transcription
factors in the adult mouse brain (P60). LEF1 and TCF7L2
proteins were observed in the thalamus and midbrain by
Western blot. To determine their spatial and cell-specific
distribution with much finer detail, we performed immu-
nohistochemical staining of mouse brain sections with anti-
LEF1 and anti-TCF7L2 antibodies (summarized in Table
2). In parallel, we stained the sections with a b-catenin-
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specific antibody to examine the subcellular localization of
b-catenin and its co-localization with LEF1 and TCF7L2.
In the telencephalon, widespread LEF1 expression was
observed only in the lateral division of the entorhinal
cortex, mostly at the level of layer V (Fig. 4a). Double
immunofluorescent staining of LEF1 and b-catenin did not
show nuclear b-catenin in these cells (Fig. 4b).
In the corpus callosum (cc), other white matter struc-
tures, and throughout the cerebral cortex, hippocampal
formation, and striatum, we observed several scattered
cells with high levels of TCF7L2 protein but a non-neu-
ronal phenotype, determined by double immunofluores-
cence with the neuronal marker NeuN (Fig. 4c, d), which
could be the previously described oligodendrocyte lineage
cells (Fancy et al. 2009; Ye et al. 2009) In the ventral
pallidum (VP), horizontal limb of the diagonal band, sub-
stantia innominata, and preoptic area, few cells were found
that co-localized TCF7L2 and nuclear b-catenin (Fig. 4e).
Double immunofluorescent staining with NeuN showed
that this population of TCF7L2-positive cells contained
both neuronal and non-neuronal cells (Fig. 4f).
In the prethalamus, we observed nuclear labeling of
TCF7L2 and b-catenin in some cells of the pregeniculate
nucleus (formerly ventral lateral geniculate), with a higher
density of stained cells in the magnocellular part (Fig. 5a).
No staining of LEF1, TCF7L2, or nuclear b-catenin was
observed in the reticular thalamic nucleus (Fig. 5b). In the
epithalamus, LEF1 was detected at relatively low levels,
mostly in the medial habenula (Fig. 5c). Nuclear TCF7L2
and b-catenin were observed in a high number of cells in
the medial habenula but were not detected in the lateral
habenula.
Consistent with the RT-qPCR analyses, the thalamus
was the region with the highest expression of both tran-
scription factors and nuclear b-catenin. LEF1 was detected
in virtually all thalamic nuclei, although with different
relative intensities or numbers of cells that express the
protein (Fig. 6a). LEF1 expression was easily detected in
all ventral, mediodorsal, posterior, lateral posterior, lat-
erodorsal, medial nuclei and dorsal lateral geniculate
nucleus. The expression was relatively less visible in
anteroventral, anteromedial, reunions, and rhomboid
nuclei. By contrast, the protein was not detected in rostral
paraventricular thalamic nucleus and in lateral part of
parafascicular nucleus. Similarly, the anterodorsal nucleus
and rostral intralaminar nuclei (central medial, paracentral,
central lateral, and intermediodorsal) were stained at a
relatively low level. In the case of TCF7l2, the intensity of
the staining was consistently high across all thalamic
derivatives (Fig. 6a), with only a relatively lower signal in
mediodorsal and ventral posterolateral nuclei. Lateral
posterior and posterior nuclei exhibited the highest relative
intensity among all of the brain regions analyzed. Finally,
nuclear b-catenin staining was seen in nearly all thalamic
nuclei (Fig. 6a). The intensity of the labeling was partic-
ularly high in the caudal part of the paraventricular
nucleus, similar to the observations in the medial habenula.
Staining in the anteromedial and centromedial nuclei was
relatively moderate. Double immunofluorescent staining
showed that LEF1- and TCF7L2-positive cells were also
Fig. 4 Distribution of LEF1, TCF7L2, and b-catenin proteins in the
telencephalon. a, b LEF1 is highly expressed in the entorhinal cortex
and does not co-localize with nuclear b-catenin. c Single TCF7L2
non-neuronal cells are found in the corpus callosum and cerebral
cortex. e The expression of TCF7L2 and nuclear b-catenin is found in
the substantia innominata and neighboring structures in f neuronal
and non-neuronal cells. ac anterior commissure; cc corpus callosum;
CX cerebral cortex; Ent entorhinal cortex; HDB nucleus of the
horizontal limb of the diagonal band; LPO lateral preoptic area;
SI substantia innominata; VP ventral pallidum. Scale bar 200 lm for
a and e. Scale bar 25 lm in b, c, d, and f
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b-catenin positive (Fig. 6b, c), and co-labeling with NeuN
confirmed their neuronal phenotype (Fig. 6d).
Cells in the pretectal region, including the large anterior
pretectal nuclei (not shown), showed relatively moderate
labeling for TCF7L2 with nuclear b-catenin but not LEF1
staining (Fig. 7a). Similar to the thalamus, TCF7L2-posi-
tive cells showed NeuN staining (Fig. 7b).
At the midbrain level TCF7L2, LEF1 and nuclear
b-catenin were detected mainly in the superior colliculus
(SC) and inferior colliculus (IC), and in the basal plate of
the midbrain only few, scattered, TCF7L2-positive cells
were observed (data not shown). In the SC, LEF1 and
nuclear b-catenin were observed in all layers at a relatively
moderate level (Fig. 7c). TCF7L2 was observed in the
superficial layers but only in a scattered group of cells that
showed labeling in the optic, intermediate, and deep layers
(Fig. 7c). In the periaqueductal gray, LEF1 was detected
only in the dorsomedial and dorsolateral parts (Fig. 7d),
whereas TCF7L2 was seen in the dorsomedial, dorsolat-
eral, and lateral parts. Nuclear b-catenin was observed in
some groups of cells in the dorsal parts and to a lesser
extent in the lateral part. At the level of the IC, we
observed a high number of TCF7L2-positive cells com-
pared with the SC, whereas LEF1 was not detected, and
only few cells showed nuclear b-catenin staining (Fig. 7e).
Combined immunofluorescence staining in the midbrain
indicated that most of the TCF7L2-positive cells were
neurons (Fig. 7f), but we also found some NeuN-negative
cells in the IC, previously described to be Olig2-positive
cells (Nazwar et al. 2009). Finally, in the rombencephalon,
we detected TCF7L2 in the medial portion of the interpe-
duncular nucleus (Fig. 7g).
In summary, LEF1 and TCF7L2 proteins were observed
in the epithalamus (only in the medial habenula), thalamus,
and midbrain (both proteins in the SC but only TCF7L2 in
the IC). The apparent presence of nuclear b-catenin in
these structures implies the involvement of LEF1 and
TCF7L2 proteins in the regulation of gene expression.
Discussion
A growing body of evidence has implicated the effectors of
canonical Wnt signaling, b-catenin and LEF1/TCF tran-
scription factors, in mental and affective disorders. How-
ever, little is known about their actual physiological role in
the adult brain. Here, we present in-depth study of LEF1/
TCF mRNA and protein expression and isoform diversity
in the adult mouse brain. We showed that TCF7L2 and
LEF1 are highly expressed in the adult thalamus, with even
Fig. 5 Distribution of LEF1, TCF7L2, and b-catenin proteins in the
adult prethalamus and epithalamus. a TCF7L2 and nuclear b-catenin
are present in the subsets of cells in the pregeniculate nucleus. b A
clear border is seen between LEF1-, TCF7L2-, and nuclear b-catenin-
positive cells between the thalamus and reticular thalamic nucleus.
c In the habenula, LEF1, TCF7L2, and nuclear b-catenin are present
only in the medial part. DLG dorsal lateral geniculate; LHb lateral
habenula; MHb medial habenula; PG pregeniculate nucleus; RT
reticular thalamic nucleus; VPL ventral posterolateral thalamic
nucleus. Scale bar 100 lm
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higher levels at perinatal stages. We also showed that both
transcription factors are expressed in other brain regions,
including mainly the entorhinal cortex, ventral and medial
pallidum, pretectum, superior and inferior colliculi, and
periaqueductal gray. TCF7L2- and LEF1-positive cells
were most often neurons, and the presence of TCF7L2 and/
or LEF1 proteins correlated with the nuclear localization of
b-catenin. The co-occurrence of the Wnt effectors in the
specific subcortical structures specialized in the integration
of diverse sources of sensory information suggests a role in
Fig. 6 Distribution of LEF1, TCF7L2, and b-catenin proteins in the
adult thalamus. a Photomicrographs show the localization of LEF1,
TCF7L2, and nuclear b-catenin at different rostro-caudal levels of the
thalamus. Double immunofluorescent staining shows that in thalamic
cells that express b LEF1 and c TCF7L2 exhibit nuclear localization
of b-catenin. d The colabeling with NeuN confirmed the neuronal
phenotype of TCF7L2-poitive cells. For abbreviations, see list. Scale
bar 200 lm for a. Scale bar 50 lm for b–d
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coherent behavior, which is disrupted in some psychiatric
disorders. Interestingly, both transcription factors under-
went substantial isoform transitions during thalamic
development, suggesting a developmental switch in gene
expression regulation by LEF1/TCF and b-catenin.
Expression of LEF1/TCFs in the developing and adult
mouse cortex, thalamus, and midbrain
Wnt signaling has been shown to influence thalamic and
midbrain patterning during embryonic development
(McMahon and Bradley 1990; Thomas and Capecchi 1990;
Pinson et al. 2000; Braun et al. 2003; Zhou et al. 2004;
Hagemann and Scholpp 2012). The transcriptional output of
the Wnt signaling pathway is mediated by the four LEF1/
TCF paralogous effectors (Arce et al. 2006; Archbold et al.
2012). Only two of them, Lef1 and Tcf7l2, are expressed in
the developing mouse brain after E10.5 (Oosterwegel et al.
1993; Korinek et al. 1998b). The expression domain of
Tcf7l2 largely identifies the thalamus, pretectum, and alar
part of the midbrain (SC and IC; with regional intensity
differences), and Lef1 is expressed in part of the telen-
cephalon, thalamus, premammillary nucleus, and alar part
of the midbrain (Oosterwegel et al. 1993; Cho and Dressler
1998; Jones and Rubenstein 2004; Bluske et al. 2009;
Shimogori et al. 2010; Puelles et al. 2011). Previous in situ
hybridization analyses showed that Lef1 and Tcf7l2 are still
expressed in the adult mouse brain specifically in the
Fig. 7 Distribution of LEF1, TCF7L2, and b-catenin proteins in the
adult pretectum and midbrain. a The pretectal area exhibited
TCF7L2- and b-catenin-positive cells, b which have a neuronal
phenotype. c In the midbrain, LEF1 and nuclear b-catenin are
expressed in all layers of the superior colliculus, whereas some
TCF7L2-positive cells are present only in intermediate and deep
layers. d The periaqueductal gray showed staining of both transcrip-
tion factors and nuclear b-catenin in the lateral and dorsal parts.
e Many TCF7L2-positive cells and some with nuclear b-catenin are
present in the inferior colliculus, and f they exhibit a neuronal
phenotype. g TCF7L2 is also expressed in the medial portion of the
interpeduncular nucleus. dlPAG dorsolateral periaqueductal gray;
dmPAG dorsomedial periaqueductal gray; DpG deep gray layers of
the superior colliculus; IC inferior colliculus; InG intermediate gray
layer of the superior colliculus; InW intermediate white layer of the
superior colliculus; IPN interpeduncular nucleus; lPAG lateral
periaqueductal gray; Op optic nerve layer of the superior colliculus;
pc posterior commissure; Pn pontine nuclei; PT pretectal region; SuG
superficial gray layer of the superior colliculus. Scale bar 100 lm for
a. Scale bar 20 lm for b and f. Scale bar 200 lm for c–e
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thalamus, and Lef1 is also expressed in the pretectum and
alar midbrain (Jones and Rubenstein 2004; Shimogori et al.
2004; Lee et al. 2009). Our qPCR results are consistent with
these studies and provide additional quantitative data,
allowing comparisons of mRNA copy numbers among the
members of the LEF1/TCF family. Although the general
mRNA expression of Tcf7 and Tcf7l1 is very low in the
forebrain and midbrain during late gestation and adulthood,
Tcf7l2 and Lef1 exhibit substantial expression in these brain
regions throughout development and adulthood. Tcf7l2 is
predominantly expressed in the embryonic thalamus and
midbrain and practically not expressed in the cortex. Lef1
exhibits moderate expression in the thalamus. The expres-
sion of Tcf7l2 but not Lef1 decreases postnatally, although
its mRNA levels are still high. Therefore, the expression of
Tcf7l2 and Lef1 in the thalamus and midbrain is maintained
during adult stages, unlike many developmental transcrip-
tion factors, such as Dbx1, Dlx2, Gbx2, Olig3, Lhx1, Lhx2,
Ngn1, Ngn2, Pax6, and Sox14 (Jones and Rubenstein 2004;
Vue et al. 2007; Chen et al. 2009) as determined in the
Allen Brain Atlas (http://mouse.brain-map.org; accessed 12
June 2012). This might suggest that these transcription
factors are ‘‘terminal selectors’’ of these brain structures
(Flames and Hobert 2009; Liu et al. 2010; Eade et al. 2012;
Kratsios et al. 2012), i.e., their activity is required not only
during development but also for the proper maturation and
function of the thalamus and midbrain in adulthood. This
is also supported by recent results indicating that thalamic
identity continuously requires b-catenin signaling for its
maintenance (Bluske et al. 2012).
The adult brain expresses a unique combination
of LEF1 and TCF7L2 isoforms
Our analysis revealed that the adult mouse brain expresses
a distinct combination of LEF1/TCF protein isoforms
compared with the embryonic brain or any other adult or
developing tissue. First, both Tcf7l2 and Lef1 exhibit
changes in isoform composition during brain development.
The adult thalamus shows a predominance of full-length
Tcf7l2 isoforms, in contrast to developing stages during
which the most prominent are the truncated isoforms that
lack the b-catenin-binding domain and thus act as domi-
nant-negative isoforms. In the case of Lef1, our analysis
revealed a developmentally regulated increase in the
inclusion of exon 6, which encodes a part of the domain
involved in protein–protein interactions with different
cofactors (Giese et al. 1995; Bruhn et al. 1997; Balmelle
et al. 2004). An increase in exon 6 inclusion was also
observed during thymus development and contributed to
the activation of T cell antigen receptor a enhancer, the
most critical checkpoint in T cell maturation (Carlsson
et al. 1993; Mallory et al. 2011). Interestingly, during the
first 3 postnatal weeks, the thalamus undergoes major
morphological, neurochemical, and electrophysiological
changes (Ramoa and McCormick 1994; De Biasi et al.
1997; Kidd and Isaac 1999; Parri and Crunelli 2002;
Noutel et al. 2011); whether the developmental changes in
the ratio between dominant-negative and full-length
TCF7L2 isoforms and/or LEF1’s alternative splicing iso-
form are involved in these processes needs further
investigation.
Second, the isoform composition of TCF7L2 in the brain
is highly tissue specific compared with the broader
expression of the other isoforms (Weise et al. 2010),
present study). The main thalamic splice variant of
TCF7L2 results from the coordinated exclusion of exon 4,
sequence inclusion from the alternative 50 splice site in
exon 7, and exclusion from the alternative 30 splice site of
exon 9, which all encode parts of the ‘‘variable domain.’’
This region of the protein is located between the b-catenin
and DNA-binding domains and has also been implicated in
protein–protein interactions (Arce et al. 2006; Archbold
et al. 2012). Furthermore, these alternative splicing events
have been shown to influence transactivation activity and
regulate the posttranslational modification of TCF7L2
(Pukrop et al. 2001; Weise et al. 2010).
Finally, the C-terminal part of TCFs exhibits complex
alternative splicing regulation (Hovanes et al. 2000; Arce
et al. 2006; Weise et al. 2010; Archbold et al. 2012).
Interestingly, TCF7L2 expressed in the adult thalamus
have a truncated C clamp, consistent with previous reports.
The TCF7L2-S isoform was shown to be particularly
abundant in the perinatal brain (Weise et al. 2010) and we
demonstrated that it is also the predominant isoform in the
adult thalamus and midbrain. The presence of a complete C
clamp is indispensable for activation of genes implicated in
proliferation (Hovanes et al. 2001; Hecht and Stemmler
2003; Atcha et al. 2007; Chang et al. 2008; Hoverter et al.
2012). In turn, the biological role of the TCF7L2-S iso-
forms is currently unknown. It has been shown that these
isoforms bind DNA with lower efficiency, thus their
transactivation capacity may rely more on protein–protein
interactions than on DNA-binding specificity (Arce et al.
2006; Weise et al. 2010), allowing the regulation of dif-
ferent sets of genes in different molecular contexts (Mayall
et al. 1997; Vadlamudi et al. 2005; Mahmoudi et al. 2010).
We suppose that the lack of C clamp could provide
molecular basis for neuron-specific regulation of gene
expression by TCF7L2.
Functional implication of differential patterns of LEF1
and TCF7L2 localization in the brain
The LEF1 and TCF7L2 proteins are particularly abundant
in the thalamus and alar plate of the midbrain, and their
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expression domains often overlap, but their detailed local-
ization shows some specific differences that may have
functional implications given the specific functional
diversification of the paralogs (Klingel et al. 2012). For
example, in the thalamus—a central integrator of sensory
information—TCF7L2 is prominent in every nuclei,
whereas the LEF1 levels is relatively low or very low in
some midline and intralaminar nuclei that provide projec-
tions to both the cortex and striatum (Sherman and Guillery
2002; Van der Werf et al. 2002; Basso et al. 2005; Jones
2009). The relative level of LEF1 is higher in the nuclei
classified as first-order relays, which are implicated in the
transmission and modification of sensory, auditory, and
visual information to the cortex and are not connected with
the striatum (Steriade 1997; Sherman and Guillery 2002).
In the epithalamus, a node that links the forebrain and
midbrain regions involved in regulating emotional behavior
(Bianco and Wilson 2009; Hikosaka 2010; Aizawa et al.
2011), only the medial habenula exhibits the presence of
both transcription factors. Interestingly, both divisions of
the habenula have distinct functions and neuronal connec-
tivity. The medial part projects almost exclusively to the
interpeduncular nucleus (IP), where we found that it is one
of the few nuclei in the rombencephalon that exhibit
TCF7L2 expression. Moreover, according to a recent gen-
oarchitectonic study in chickens (Lorente-Ca´novas et al.
2012), the IP is subdivided into several portions. Our data
suggest that these TCF7L2-positive cells are possibly part
of the caudal centromedial subnucleus of the IP described in
the avian study. In the superior colliculus, we also observed
differences in the localization of LEF1 and TCF7L2
between functionally distinct subdivisions. LEF1 is appar-
ently present in all layers, but TCF7L2 seems to be absent
from the superficial gray and upper optic layers, which
receive visual inputs from the retina and process visual
information (Langer and Lund 1974). The deep layers are
responsible for the integration of sensorimotor information
(Krauzlis et al. 2004; May 2006; Cuppini et al. 2010) and
reciprocally interconnected with the periaqueductal gray
(PAG), which plays a critical role in various emotion-
related, automatic, and reflex-like behaviors (Bandler and
Shipley 1994; Floyd et al. 2000; Keay and Bandler 2001).
Both the SC and PAG are also connected with thalamic
nuclei (Krout and Loewy 2000; Krout et al. 2001).
Intriguingly, the regions that express LEF1 and/or
TCF7L2 are involved in the integration of information
from many sources and highly interconnected with each
other. They are also implicated in many psychiatric dis-
orders (Kang et al. 2008; Byne et al. 2009; Dommett et al.
2009; Cronenwett and Csernansky 2010; Hikosaka 2010;
Pinault 2011; Fowler and Kenny 2012). The presence of
LEF1 and TCF7L2 proteins in the thalamus and ventral
midbrain correlates with nuclear b-catenin, suggesting that
these transcription factors indeed regulate gene expression.
For example, we previously showed that the LEF1/
b-catenin complex in the thalamus regulates the expression
of the Cacna1g gene, which encodes a voltage-gated
T-type calcium channel (Wisniewska et al. 2010). Future
studies will shed light on the target networks regulated by
these transcription factors in the different brain structures
and the extent to which the networks of LEF1 and TCF7L2
are functionally redundant.
Conclusion
Our results showed that specific LEF/TCFs paralogs with a
unique combination of isoforms are expressed in partially
overlapping regions of the adult brain. Importantly, each
paralog and isoform has been reported to have distinct
properties, including specific protein–protein interactions
with co-factors, different transactivation capabilities, and
different target specificities. Therefore, the effects of gene
expression regulation by LEF/TCFs are expected to be
substantially different in the adult brain from those in non-
neural tissues or in embryonic stages.
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